Effect of Barley Supplemented Wheat Bread on Markers of Cardiovascular and Renal Health
- Conditions
- Cardiovascular DiseasesKidney Diseases
- Interventions
- Other: Effect of Barley Supplemented Wheat Bread on markers of Cardiovascular and Renal Health
- Registration Number
- NCT05312788
- Lead Sponsor
- Khyber Medical University Peshawar
- Brief Summary
The disruption of colonic microbiota has been linked to a number of diseases, mainly cardiovascular and kidney diseases. One possible means to improve the microbiota is to increase dietary fiber intake as the intake of dietary fiber shifts the fermentation from proteolytic saccharolytic fermentation.
Beta-glucans are soluble dietary fibers mainly found in oats and barley. Results from previous studies suggest that the consumption of barley reduces the risk of cardiovascular and kidney diseases. Therefore, this study will explore the effect of barley beta-glucans on markers of Cardiovascular and Renal health.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 25
- Healthy individuals of age 18 years or older
- BMI ranged between 18.5 and 24.9
- Celiac disease, Cancer, Diabetes , cardiovascular diseases
- Gastro intestinal tract disease
- Pregnant women
- Use of pre-, pro- or antibiotics 15 days before the enrollment into the study
- Food allergy to food used in the trial
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Whole wheat bread Effect of Barley Supplemented Wheat Bread on markers of Cardiovascular and Renal Health Whole wheat bread will be used as control bread. Barley supplemented wheat bread Effect of Barley Supplemented Wheat Bread on markers of Cardiovascular and Renal Health Barley supplemented wheat bread (50% substitution) will be used as experimental bread.
- Primary Outcome Measures
Name Time Method Change in Serum Nitric oxide from baseline to 4 weeks Baseline and after 4 weeks change in Serum E-selectin from baseline to 4 weeks Baseline and after 4 weeks Change in Serum P-cresyl sulfate from baseline to 4 weeks Baseline and after 4 weeks Change in Serum Thiobarbituric acid reactive substances (TBARs) from baseline to 4 weeks Baseline and after 4 weeks Change in Serum Total antioxidant capacity (TAC) from baseline to 4 weeks Baseline and after 4 weeks Change in Serum Indoxyl sulfate from baseline to 4 weeks Baseline and after 4 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Khyber Medical University, Peshawar
🇵🇰Peshawar, KPK, Pakistan